These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23820461)

  • 1. Economic impact of ambulatory care formulary restrictions at a large county health system.
    Centeno A; Price V; Robinson N; Tomecko GW; Sedam B
    Am J Health Syst Pharm; 2013 Jul; 70(14):1238-43. PubMed ID: 23820461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a comprehensive pharmaceutical care program for an underserved population.
    Mascardo LA; Spading KA; Abramowitz PW
    Am J Health Syst Pharm; 2012 Jul; 69(14):1225-30. PubMed ID: 22761077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a pharmacist-run call center on medication access for ambulatory care patients.
    Bartlett D; Evans P; Sullivan M
    Am J Health Syst Pharm; 2009 Sep; 66(18):1666-8. PubMed ID: 19729572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a Prescription-Assistance Program for Medically Uninsured Patients With Cancer: Case Study of a Public Hospital Experience in New York State.
    Gao L; Joseph J; Santoro-Levy M; Gotlieb VK; Multz AS
    J Oncol Pract; 2014 Mar; 10(2):104. PubMed ID: 29452556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K; Basu A; Hansen RN; Watkins JB; Sullivan SD
    Med Care; 2017 Feb; 55(2):191-198. PubMed ID: 27579915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.
    Lee JJ; Sack DE; Kam S; Reed SC; Carew B; Lloyd C; Weaver EO; Miller RF
    J Community Health; 2023 Dec; 48(6):919-925. PubMed ID: 37284916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of outcomes associated with restricted access to atypical antipsychotics.
    Rajagopalan K; Hassan M; Boswell K; Sarnes E; Meyer K; Grossman F
    Am J Manag Care; 2016 Jun; 22(6):e208-14. PubMed ID: 27355908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost.
    Castellon YM; Bazargan-Hejazi S; Masatsugu M; Contreras R
    Am J Manag Care; 2014 Feb; 20(2):146-50. PubMed ID: 24738532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description and financial impact of ambulatory care pharmacy team interventions within an underserved patient population.
    Hasham S; Moye-Dickerson P; Thurston MM
    Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S42-S48. PubMed ID: 36371741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
    Kirking DM; Ascione FJ; Richards JW
    Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.
    Gao L; Joseph J; Santoro-Levy M; Multz AS; Gotlieb VK
    Hosp Pharm; 2016 Jul; 51(7):572-6. PubMed ID: 27559190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CareFirst Patient-Centered Medical Home Program: Cost and Utilization Effects in Its First Three Years.
    Cuellar A; Helmchen LA; Gimm G; Want J; Burla S; Kells BJ; Kicinger I; Nichols LM
    J Gen Intern Med; 2016 Nov; 31(11):1382-1388. PubMed ID: 27473005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic.
    Jones RA; Lopez LM; Beall DG
    Hosp Pharm; 1991 Sep; 26(9):778-82. PubMed ID: 10114011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research.
    Singhal PK; Raisch DW; Gupchup GV
    Ann Pharmacother; 1999 Dec; 33(12):1336-55. PubMed ID: 10630834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulary-control procedures in a staff-model health maintenance organization.
    Lyon RA
    Am J Hosp Pharm; 1990 Feb; 47(2):340-2. PubMed ID: 2106782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.